Tapewire

NYSE · USD

MAIA

MAIA Biotechnology, Inc.

Export transactions ↓
Tapewire entity
6919
SEC CIK
0001878313
Parsed reports
248

Last 12 months

Inside the activity.

30 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025140
Dec 202560
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202630
Jul 202600
Aug 202650
Sep 202620
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 28, 2023 Filed May 1, 2023 10:30 UTC
Vitoc VladDirector · Chief Executive Officer · 10% owner
PurchaseCommon Stock 4,000 $2.50 $10,000.00
Disclosure

SEC source: 0001127602-23-013819 · form4.xml · nonDerivative · entry 1

Vitoc Vlad · CIK 0001913257 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 809,121

F1 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.49 to $2.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
April 27, 2023 Filed Apr 28, 2023 10:52 UTC
MCGUIRE JOSEPH FChief Financial Officer
PurchaseCommon Stock 4,400 $2.25 $9,900.00
Disclosure

SEC source: 0001127602-23-013714 · form4.xml · nonDerivative · entry 1

MCGUIRE JOSEPH F · CIK 0001243988 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,400

F1 · kind: These shares were purchased by the reporting person in the issuer's follow-on offering, which closed on April 27, 2023.

Read SEC document
April 27, 2023 Filed Apr 28, 2023 10:50 UTC PurchaseCommon Stock 8,500 $2.25 $19,125.00
Disclosure

SEC source: 0001127602-23-013712 · form4.xml · nonDerivative · entry 1

Guerrero Ramiro · CIK 0001913253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 311,472.04

F1 · kind: These shares were purchased by the reporting person in the issuer's follow-on offering, which closed on April 27, 2023.

Read SEC document
April 27, 2023 Filed Apr 28, 2023 10:49 UTC PurchaseCommon Stock 48,000 $2.25 $108,000.00
Disclosure

SEC source: 0001127602-23-013710 · form4.xml · nonDerivative · entry 1

Louie Ngar Yee · CIK 0001913264 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 976,584

F1 · kind: These shares were purchased by the reporting person in the issuer's follow-on offering, which closed on April 27, 2023.

Read SEC document
April 27, 2023 Filed Apr 28, 2023 10:46 UTC
Smith StanDirector
PurchaseCommon Stock 133,300 $2.25 $299,925.00
Disclosure

SEC source: 0001127602-23-013708 · form4.xml · nonDerivative · entry 1

Smith Stan · CIK 0001913199 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 686,628

F1 · kind: These shares were purchased by the reporting person in the issuer's follow-on offering, which closed on April 27, 2023.

F2 · ownership.nature: These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

Read SEC document
April 20, 2023 Filed Apr 21, 2023 11:53 UTC
Smith StanDirector
PurchaseCommon Stock 10,000 $3.74 $37,400.00
Disclosure

SEC source: 0001127602-23-013327 · form4.xml · nonDerivative · entry 1

Smith Stan · CIK 0001913199 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 553,328

F1 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.50 to $3.95, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

F1 · ownership.nature: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

Read SEC document
April 18, 2023 Filed Apr 19, 2023 10:55 UTC PurchaseCommon Stock 1,263 $4.17 $5,266.71
Disclosure

SEC source: 0001127602-23-013177 · form4.xml · nonDerivative · entry 1

Guerrero Ramiro · CIK 0001913253 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 302,972.04

F1 · price: The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.01 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
April 17, 2023 Filed Apr 18, 2023 12:42 UTC PurchaseCommon Stock 1,576 $3.69 $5,815.44
Disclosure

SEC source: 0001127602-23-013028 · form4.xml · nonDerivative · entry 1

Luput Cristian · CIK 0001913350 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 295,068

F1 · price: The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Luput that is intended to comply with the Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.60 to $3.85, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
April 14, 2023 Filed Apr 17, 2023 11:01 UTC PurchaseCommon Stock 802 $3.58 $2,871.16
Disclosure

SEC source: 0001127602-23-012944 · form4.xml · nonDerivative · entry 2

Luput Cristian · CIK 0001913350 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 293,492

F1 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of Mr. Luput that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.55 to $3.65, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
April 13, 2023 Filed Apr 17, 2023 11:01 UTC PurchaseCommon Stock 622 $3.62 $2,251.64
Disclosure

SEC source: 0001127602-23-012944 · form4.xml · nonDerivative · entry 1

Luput Cristian · CIK 0001913350 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 292,690

F1 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of Mr. Luput that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.57 to $3.70, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
April 04, 2023 Filed Apr 5, 2023 10:48 UTC
Vitoc VladDirector · Chief Executive Officer · 10% owner
PurchaseCommon Stock 925 $3.56 $3,293.00
Disclosure

SEC source: 0001127602-23-012463 · form4.xml · nonDerivative · entry 3

Vitoc Vlad · CIK 0001913257 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 805,121

F2 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F4 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.53 to $3.60, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 10:48 UTC
Vitoc VladDirector · Chief Executive Officer · 10% owner
PurchaseCommon Stock 1,375 $3.50 $4,812.50
Disclosure

SEC source: 0001127602-23-012463 · form4.xml · nonDerivative · entry 2

Vitoc Vlad · CIK 0001913257 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 804,196

F2 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.45 to $3.60, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 31, 2023 Filed Apr 3, 2023 13:32 UTC
Vitoc VladDirector · Chief Executive Officer · 10% owner
PurchaseCommon Stock 1,495 $3.46 $5,172.70
Disclosure

SEC source: 0001127602-23-011737 · form4.xml · nonDerivative · entry 2

Vitoc Vlad · CIK 0001913257 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 802,821

F1 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.44 to $3.48, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 10:36 UTC
Smith StanDirector
GrantStock Options · Derivative 7,094 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001127602-23-012021 · form4.xml · derivative · entry 1

Smith Stan · CIK 0001913199 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · see footnote

Disclosed balance after: 7,094

Underlying: Common Stock · 7,094 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The stock options, granted on March 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.

F2 · ownership.nature: These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 10:34 UTC GrantStock Options · Derivative 5,675 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001127602-23-012019 · form4.xml · derivative · entry 1

Guerrero Ramiro · CIK 0001913253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,675

Underlying: Common Stock · 5,675 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The stock options, granted on March 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 10:33 UTC GrantStock Options · Derivative 5,675 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001127602-23-012017 · form4.xml · derivative · entry 1

CHAOUKI STEVEN M · CIK 0001776865 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,675

Underlying: Common Stock · 5,675 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The stock options, granted on March 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 10:32 UTC GrantStock Options · Derivative 8,513 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001127602-23-012015 · form4.xml · derivative · entry 1

Louie Ngar Yee · CIK 0001913264 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,513

Underlying: Common Stock · 8,513 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The stock options, granted on March 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 10:28 UTC GrantStock Options · Derivative 5,675 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001127602-23-012011 · form4.xml · derivative · entry 1

Luput Cristian · CIK 0001913350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,675

Underlying: Common Stock · 5,675 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The stock options, granted on March 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 10:30 UTC GrantStock Options · Derivative 945 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001127602-23-012013 · form4.xml · derivative · entry 1

Theagene Jean-Manasse · CIK 0001969857 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 945

Underlying: Common Stock · 945 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The stock options, granted on March 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.

Read SEC document
March 30, 2023 Filed Apr 3, 2023 13:32 UTC
Vitoc VladDirector · Chief Executive Officer · 10% owner
PurchaseCommon Stock 205 $3.43 $703.15
Disclosure

SEC source: 0001127602-23-011737 · form4.xml · nonDerivative · entry 1

Vitoc Vlad · CIK 0001913257 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 801,326

F1 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.41 to $3.43, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 11:45 UTC
Smith StanDirector
PurchaseCommon Stock 938 $3.49 $3,273.62
Disclosure

SEC source: 0001127602-23-011434 · form4.xml · nonDerivative · entry 1

Smith Stan · CIK 0001913199 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 543,328

F1 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.26 to $3.60, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

F1 · ownership.nature: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

Read SEC document
March 23, 2023 Filed Mar 24, 2023 12:53 UTC
Smith StanDirector
PurchaseCommon Stock 1,862 $3.43 $6,386.66
Disclosure

SEC source: 0001127602-23-011265 · form4.xml · nonDerivative · entry 2

Smith Stan · CIK 0001913199 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 542,390

F1 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

F3 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.11 to $3.51, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

F1 · ownership.nature: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

Read SEC document
March 22, 2023 Filed Mar 24, 2023 12:53 UTC
Smith StanDirector
PurchaseCommon Stock 1,458 $3.18 $4,636.44
Disclosure

SEC source: 0001127602-23-011265 · form4.xml · nonDerivative · entry 1

Smith Stan · CIK 0001913199 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 540,528

F1 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.07 to $3.39, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

F1 · ownership.nature: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

Read SEC document
March 21, 2023 Filed Mar 22, 2023 10:42 UTC
Smith StanDirector
PurchaseCommon Stock 2,736 $3.17 $8,673.12
Disclosure

SEC source: 0001127602-23-010968 · form4.xml · nonDerivative · entry 2

Smith Stan · CIK 0001913199 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 539,070

F1 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

F3 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.10 to $3.57 inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 20, 2023 Filed Mar 22, 2023 10:42 UTC
Smith StanDirector
PurchaseCommon Stock 3,006 $3.28 $9,859.68
Disclosure

SEC source: 0001127602-23-010968 · form4.xml · nonDerivative · entry 1

Smith Stan · CIK 0001913199 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 536,334

F1 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.18 to $3.345 inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 16, 2023 Filed Mar 20, 2023 20:27 UTC PurchaseCommon Stock 1,333 $3.64 $4,852.12
Disclosure

SEC source: 0001127602-23-010853 · form4.xml · nonDerivative · entry 1

Guerrero Ramiro · CIK 0001913253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 301,709.04

F1 · price: The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.55 to $3.70, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 11:45 UTC PurchaseCommon Stock 3,000 $4.07 $12,210.00
Disclosure

SEC source: 0001127602-23-009989 · form4.xml · nonDerivative · entry 2

Luput Cristian · CIK 0001913350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,068

F1 · price: The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Luput that is intended to comply with the Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.90 to $4.145, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 10, 2023 Filed Mar 13, 2023 10:27 UTC PurchaseCommon Stock 443 $3.98 $1,763.14
Disclosure

SEC source: 0001127602-23-009813 · form4.xml · nonDerivative · entry 2

Guerrero Ramiro · CIK 0001913253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,376.04

F1 · price: The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended.

F3 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.935 to $4.00, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 11:45 UTC PurchaseCommon Stock 5,382 $3.99 $21,474.18
Disclosure

SEC source: 0001127602-23-009989 · form4.xml · nonDerivative · entry 1

Luput Cristian · CIK 0001913350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 289,068

F1 · price: The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Luput that is intended to comply with the Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.985 to $4.00, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 09, 2023 Filed Mar 10, 2023 11:37 UTC PurchaseCommon Stock 2,114 $3.98 $8,413.72
Disclosure

SEC source: 0001127602-23-009696 · form4.xml · nonDerivative · entry 2

Luput Cristian · CIK 0001913350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 283,686

F1 · price: The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Luput that is intended to comply with the Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.94 to $4.00, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 10:27 UTC PurchaseCommon Stock 1,057 $3.98 $4,206.86
Disclosure

SEC source: 0001127602-23-009813 · form4.xml · nonDerivative · entry 1

Guerrero Ramiro · CIK 0001913253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 299,933.04

F1 · price: The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.87 to $4.00, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 10:25 UTC
Smith StanDirector
PurchaseCommon Stock 3,582 $4.03 $14,435.46
Disclosure

SEC source: 0001127602-23-009811 · form4.xml · nonDerivative · entry 1

Smith Stan · CIK 0001913199 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 533,328

F1 · shares: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

F2 · shares: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.87 to $4.165, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

F1 · ownership.nature: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

Read SEC document
March 08, 2023 Filed Mar 9, 2023 11:30 UTC
Smith StanDirector
PurchaseCommon Stock 3,076 $4.20 $12,919.20
Disclosure

SEC source: 0001127602-23-009534 · form4.xml · nonDerivative · entry 2

Smith Stan · CIK 0001913199 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 529,746

F1 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

F3 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.06 to $4.25 inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 08, 2023 Filed Mar 9, 2023 11:28 UTC
Vitoc VladDirector · Chief Executive Officer · 10% owner
PurchaseCommon Stock 1,581 $4.21 $6,656.01
Disclosure

SEC source: 0001127602-23-009532 · form4.xml · nonDerivative · entry 1

Vitoc Vlad · CIK 0001913257 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 801,121

F1 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.20 to $4.22, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:13 UTC
MCGUIRE JOSEPH FChief Financial Officer
GrantStock Options · Derivative 100,000 $0.00 Strike: $4.10 $0.00
Disclosure

SEC source: 0001127602-23-009777 · form4.xml · derivative · entry 1

MCGUIRE JOSEPH F · CIK 0001243988 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-03-08

F1 · derivative.exercise_date: The stock options, granted on March 8, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:12 UTC
Gryaznov SergeiChief Scientific Officer
GrantStock Options · Derivative 100,000 $0.00 Strike: $4.10 $0.00
Disclosure

SEC source: 0001127602-23-009775 · form4.xml · derivative · entry 1

Gryaznov Sergei · CIK 0001913228 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-03-08

F1 · derivative.exercise_date: The stock options, granted on March 8, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:01 UTC
Vitoc VladDirector · Chief Executive Officer · 10% owner
GrantStock Options · Derivative 200,000 $0.00 Strike: $4.10 $0.00
Disclosure

SEC source: 0001127602-23-009770 · form4.xml · derivative · entry 1

Vitoc Vlad · CIK 0001913257 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2033-03-08

F1 · derivative.exercise_date: The stock options, granted on March 8, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:06 UTC
Obrocea MihailChief Medical Officer
GrantStock Options · Derivative 100,000 $0.00 Strike: $4.10 $0.00
Disclosure

SEC source: 0001127602-23-009773 · form4.xml · derivative · entry 1

Obrocea Mihail · CIK 0001913265 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-03-08

F1 · derivative.exercise_date: The stock options, granted on March 8, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 11:37 UTC PurchaseCommon Stock 627 $4.22 $2,645.94
Disclosure

SEC source: 0001127602-23-009696 · form4.xml · nonDerivative · entry 1

Luput Cristian · CIK 0001913350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,572

F1 · price: The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Luput that is intended to comply with the Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.21 to $4.24, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 07, 2023 Filed Mar 8, 2023 11:40 UTC PurchaseCommon Stock 1,688 $4.23 $7,140.24
Disclosure

SEC source: 0001127602-23-009395 · form4.xml · nonDerivative · entry 2

Luput Cristian · CIK 0001913350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,945

F1 · price: The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Luput that is intended to comply with the Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.20 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 07, 2023 Filed Mar 8, 2023 11:37 UTC PurchaseCommon Stock 871 $4.25 $3,701.75
Disclosure

SEC source: 0001127602-23-009394 · form4.xml · nonDerivative · entry 2

Guerrero Ramiro · CIK 0001913253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,876.04

F1 · price: The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended.

F3 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.22 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 07, 2023 Filed Mar 8, 2023 11:34 UTC
Vitoc VladDirector · Chief Executive Officer · 10% owner
PurchaseCommon Stock 1,439 $4.24 $6,101.36
Disclosure

SEC source: 0001127602-23-009392 · form4.xml · nonDerivative · entry 3

Vitoc Vlad · CIK 0001913257 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 799,540

F2 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F4 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.21 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 07, 2023 Filed Mar 9, 2023 11:30 UTC
Smith StanDirector
PurchaseCommon Stock 1,961 $4.23 $8,295.03
Disclosure

SEC source: 0001127602-23-009534 · form4.xml · nonDerivative · entry 1

Smith Stan · CIK 0001913199 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 526,670

F1 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.20 to $4.25 inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 11:33 UTC
Smith StanDirector
PurchaseCommon Stock 4,594 $4.39 $20,167.66
Disclosure

SEC source: 0001127602-23-009205 · form4.xml · nonDerivative · entry 2

Smith Stan · CIK 0001913199 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 524,709

F1 · shares: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

F3 · shares: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.23 to $4.50 inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

F1 · ownership.nature: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 11:40 UTC PurchaseCommon Stock 527 $4.24 $2,234.48
Disclosure

SEC source: 0001127602-23-009395 · form4.xml · nonDerivative · entry 1

Luput Cristian · CIK 0001913350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 279,257

F1 · price: The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Luput that is intended to comply with the Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.23 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 11:37 UTC PurchaseCommon Stock 481 $4.24 $2,039.44
Disclosure

SEC source: 0001127602-23-009394 · form4.xml · nonDerivative · entry 1

Guerrero Ramiro · CIK 0001913253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,005.04

F1 · price: The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.23 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 11:34 UTC
Vitoc VladDirector · Chief Executive Officer · 10% owner
PurchaseCommon Stock 544 $4.24 $2,306.56
Disclosure

SEC source: 0001127602-23-009392 · form4.xml · nonDerivative · entry 2

Vitoc Vlad · CIK 0001913257 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 798,101

F2 · price: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.23 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 03, 2023 Filed Mar 6, 2023 11:19 UTC
Vitoc VladDirector · Chief Executive Officer · 10% owner
PurchaseCommon Stock 2,398 $4.47 $10,719.06
Disclosure

SEC source: 0001127602-23-008972 · form4.xml · nonDerivative · entry 2

Vitoc Vlad · CIK 0001913257 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 797,557

F1 · shares: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.

F3 · shares: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.39 to $4.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 11:33 UTC
Smith StanDirector
PurchaseCommon Stock 2,509 $4.43 $11,114.87
Disclosure

SEC source: 0001127602-23-009205 · form4.xml · nonDerivative · entry 1

Smith Stan · CIK 0001913199 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 520,115

F1 · shares: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

F2 · shares: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.39 to $4.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

F1 · ownership.nature: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

Read SEC document
March 02, 2023 Filed Mar 3, 2023 11:10 UTC
Smith StanDirector
PurchaseCommon Stock 23 $4.41 $101.43
Disclosure

SEC source: 0001127602-23-008532 · form4.xml · nonDerivative · entry 2

Smith Stan · CIK 0001913199 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 517,606

F1 · ownership.nature: The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.